![]()
Combinations ; See Below
| Brand Name | Manufacturer Name | Distributor | Drug Strength | Packaging | Formulation | Formulation Strength | Price |
|---|---|---|---|---|---|---|---|
| Valcyte | Roche | Roche Products | 450mg | 60 | Tablet | per tablet | KES 244,407.00 |
| Valganciclovir More info | |
|---|---|
| Mode Of Action | Inhibits viral DNA replication. |
| Drug Indication | cytomegalovirus (CMV) infection in immunocompromised patients |
| Precautions | |
| Contra-Indications | |
| Side Effects | |
| Dosage | Adults - Induction: 900 mg BD x 3/52: Maintenance: 900 mg OD. Prevention of CMV Disease in from 4 months - to 16 yrs after organ transplant:Paediatric Dose [mg] = 7 x BSA x CrCl |
| Special Information | L-valyl ester of ganciclovir (a prodrug for ganciclovir). |
| Pregnancy Category | Category C |
| Pregnancy Category Description | Drugs which, owing to their pharmacological effects, or may be suspected of causing detrimental effects on human foetus or neonates without causing malfunctions. These effects may be reversible |
| Drug Category | DRUGS ACTING ON INFECTIONS |
| Drug Sub-Category | Anti-Viral Drugs |